School of Life Sciences, Chinese University of Hong Kong, Shatin, NT, Hong Kong 999077, China.
College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
Molecules. 2021 Jun 21;26(12):3766. doi: 10.3390/molecules26123766.
Rutin (R) and quercetin (Q) are two widespread dietary flavonoids. Previous studies regarding the plasma cholesterol-lowering activity of R and Q generated inconsistent results. The present study was therefore carried out to investigate the effects of R and Q on cholesterol metabolism in both HepG2 cells and hypercholesterolemia hamsters. Results from HepG2 cell experiments demonstrate that both R and Q decreased cholesterol at doses of 5 and 10 µM. R and Q up-regulated both the mRNA and protein expression of sterol regulatory element binding protein 2 (SREBP2), low-density lipoprotein receptor (LDLR), and liver X receptor alpha (LXRα). The immunofluorescence study revealed that R and Q increased the LDLR expression, while only Q improved LDL-C uptake in HepG2 cells. Results from hypercholesterolemia hamsters fed diets containing R (5.5 g/kg diet) and Q (2.5 g/kg diet) for 8 weeks demonstrate that both R and Q had no effect on plasma total cholesterol. In the liver, only Q reduced cholesterol significantly. The discrepancy between the in vitro and in vivo studies was probably due to a poor bioavailability of flavonoids in the intestine. It was therefore concluded that R and Q were effective in reducing cholesterol in HepG2 cells in vitro, whereas in vivo, the oral administration of the two flavonoids had little effect on plasma cholesterol in hamsters.
芦丁(R)和槲皮素(Q)是两种广泛存在的膳食类黄酮。之前关于 R 和 Q 降低血浆胆固醇活性的研究结果并不一致。因此,本研究旨在探讨 R 和 Q 对 HepG2 细胞和高胆固醇血症仓鼠胆固醇代谢的影响。HepG2 细胞实验结果表明,R 和 Q 在 5 和 10 μM 剂量下均降低胆固醇。R 和 Q 上调固醇调节元件结合蛋白 2(SREBP2)、低密度脂蛋白受体(LDLR)和肝 X 受体α(LXRα)的 mRNA 和蛋白表达。免疫荧光研究显示,R 和 Q 增加了 LDLR 的表达,而只有 Q 改善了 HepG2 细胞中的 LDL-C 摄取。用含有 R(5.5 g/kg 饮食)和 Q(2.5 g/kg 饮食)的饮食喂养 8 周的高胆固醇血症仓鼠的结果表明,R 和 Q 对血浆总胆固醇均无影响。在肝脏中,只有 Q 显著降低胆固醇。体外和体内研究之间的差异可能是由于肠道中类黄酮的生物利用度较差。因此,结论是 R 和 Q 在体外有效降低 HepG2 细胞中的胆固醇,而在体内,两种黄酮类化合物的口服给药对仓鼠血浆胆固醇几乎没有影响。